Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Edoxaban”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03254147
What this trial is testing

Medical Need of OAC Reversal

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 53,969
Post-approval studies (Phase 4)UnknownNCT03088072
What this trial is testing

A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure

Who this might be right for
Non-Valvular Atrial FibrillationLeft Atrial Appendage Closure
Scripps Health 75
Post-approval studies (Phase 4)Ended earlyNCT02561897
What this trial is testing

EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Electrophysiology Research Foundation 5
Large-scale testing (Phase 3)Study completedNCT02072434
What this trial is testing

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 2,199
Early research (Phase 1)Study completedNCT02047565
What this trial is testing

A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation

Who this might be right for
Bleeding
Daiichi Sankyo 110
Post-approval studies (Phase 4)Study completedNCT03494530
What this trial is testing

Lixiana Acute Stroke Evaluation Registry

Who this might be right for
Ischemic StrokeAtrial FibrillationHemorrhagic Transformation Stroke
University of Alberta 70
Not applicableStudy completedNCT02964949
What this trial is testing

Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 607
Large-scale testing (Phase 3)Study completedNCT02801669
What this trial is testing

Study of DU-176b Aged 80 Years or Older

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Co., Ltd. 984
Not applicableStudy completedNCT02944019
What this trial is testing

Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 13,980
Large-scale testing (Phase 3)Ended earlyNCT04516941
What this trial is testing

CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19

Who this might be right for
SARS-CoV InfectionCOVID-19
Insel Gruppe AG, University Hospital Bern 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT04229758
What this trial is testing

Restarting Anticoagulation After Traumatic Intracranial Hemorrhage

Who this might be right for
HemorrhageIntracranial HemorrhagesBleeding+1 more
University of Texas at Austin 1,100
Not applicableLooking for participantsNCT02219984
What this trial is testing

START-Register: Survey on Anticoagulated Patients Register

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis
GUALTIERO PALARETI 15,410
Not applicableUnknownNCT04684056
What this trial is testing

Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation

Who this might be right for
Oral AnticoagulantAtrial FibrillationPharmacokinetics and Pharmacodynamics
Wuhan Asia Heart Hospital 1,864
Not applicableLooking for participantsNCT06947707
What this trial is testing

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

Who this might be right for
Cerebral Venous ThrombosisAnticoagulants and Thrombotic DisordersAnticoagulation Treatment+6 more
Xuanwu Hospital, Beijing 1,486
Testing effectiveness (Phase 2)Study completedNCT01203072
What this trial is testing

A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

Who this might be right for
Venous ThromboembolismDeep Vein ThrombosisTotal Knee Arthroplasty
Daiichi Sankyo Co., Ltd. 523
Not applicableUnknownNCT04007653
What this trial is testing

Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE

Who this might be right for
Venous Thromboembolic DiseasePost Thrombotic SyndromeChronic Thromboembolic Pulmonary Hypertension+1 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,200
Not applicableNot Yet RecruitingNCT05764356
What this trial is testing

Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II

Who this might be right for
Novel Oral AnticoagulantsNOACsRivaroxaban+9 more
Peking University First Hospital 2,000
Large-scale testing (Phase 3)Study completedNCT02073682
What this trial is testing

Cancer Venous Thromboembolism (VTE)

Who this might be right for
Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+1 more
Daiichi Sankyo 1,046
Post-approval studies (Phase 4)Study completedNCT03950076
What this trial is testing

EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)

Who this might be right for
Intracranial HemorrhagesAtrial Fibrillation
Population Health Research Institute 948
Post-approval studies (Phase 4)Study completedNCT02567461
What this trial is testing

Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel

Who this might be right for
Coronary Artery Disease
University of Florida 80
Next Page